Clinical Practice Information Notice

Title
CPI 189 – 2025 NWT Cervical Cancer Screening Clinical Practice Guidelines
CPI 188 – NWT Guidelines for the Use of Oseltamivir in Long Term Care Facilities
CPI 187 – 2025 Screening and Diagnosis of Type 2 Diabetes in Adults Clinical Practice Guidelines
CPI 186 – 2024 NWT Breast Cancer Screening Clinical Practice Guidelines
CPI 185 – NWT Infection Prevention and Control (IPAC) Program Standards
CPI 184 – 2024 NWT Colorectal Cancer Screening Clinical Practice Guidelines
CPI 183 – NWT Immunization Schedule Amendments
CPI 182 - NWT Communicable Disease Manual Amendments
CPI 181 - NWT Immunization Program Standards
CPI 180 - Lost to Follow-Up of STI Cases and Contacts Flow Chart - Amended 2023
CPI 179 – NWT Tuberculosis (TB) Program
CPI 178 - Sexually Transmitted Infection (STI) Reporting Forms
CPI 177 - NWT Sexual Health and Sexually Transmitted and Blood Borne Infection (STBBI) Program Standards
CPI 176 - Revised Enhanced Congenital Syphilis Screening, Treatment and Reporting
CPI 175 - Bacille Calmette-Guerin (BCG) Vaccine (UPDATE: July 2024)
CPI 174 - Use of Comirnaty mRNA (Pfizer-BioNTech) COVID-19 Vaccine booster dose (30 mcg) in those who are 12-17 years of age in the NWT (Revised – see CPI 183)
CPI 173 - Enhanced Congenital Syphilis Screening (Revised - see CPI 176)
CPI 172 - Use of Comirnaty mRNA (Pfizer-BioNTech) COVID-19 Vaccine in those who are 5-11 years of age in the NWT (Revised - see CPI 183)
CPI 171 - Community Based Testing for COVID-19 (rescinded January 2024)
CPI 170 - 2021 NWT Well Child Record Handbook and 2021 NWT WCR Desk Reference

Pages